Hubei Huarong Holding Co.,Ltd. (600421.SS)

CNY 8.64

(-0.35%)

Market Cap (In CNY)

1.68 Billion

Revenue (In CNY)

122.12 Million

Net Income (In CNY)

-8.27 Million

Avg. Volume

5.33 Million

Currency
CNY
Country
Consumer Cyclical
Open
-
Prev. Close
-
Day Range
-
Year Range
4.8-13.81
PE
-
EPS
-
Beta Value
0.214
ISIN
CNE000001HY9
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Consumer Cyclical
Industry
Personal Products & Services
CEO
Mr. Cai Bing Wen
Employee Count
-
Website
http://www.spring.com.cn
Ipo Date
2004-06-07
Details
Hubei Huarong Holding Co.,Ltd. produces and distributes pharmaceutical products in China. The company's principal pharmaceutical products include Gucining Capsules and Huoxue Tongmai Capsules. It also develops biological products, pharmaceuticals, environment-protection, and agricultural products, as well as related technologies. The company was formerly known as Hubei Yangfan Holding Co., Ltd. and changed its name to Hubei Huarong Holding Co.,Ltd. in November 2020. Hubei Huarong Holding Co.,Ltd. was founded in 1997 and is headquartered in Wuhan, China.